Bolo, MauriceByaruhanga, JanetVugigi, SarahWanyanga, WilberforceRonoh, WesleyNdomondo-sigonda, Margareth2020-03-312020-03-312016-12http://hdl.handle.net/10625/58729The report reviews the process of arriving at a research agenda, where inclusion comprises three dimensions: 1) Affordability, including procurement and pricing; 2) Access, related to distribution and supply chains; and 3) Quality, as it relates to standards, counterfeits and pharmaco-vigilance. Innovation, institutions and policies are cross-cutting themes that apply to factors on both the ‘competitiveness’ and ‘inclusion’ arms of the conceptual framework.application/pdfenSOCIAL INCLUSIONPHARMACEUTICAL INDUSTRYPHARMACOLOGYACCESS TO MEDICINESTANDARDSLICENSINGREGULATIONCOMPETITIVENESSTECHNOLOGY TRANSFERBOTTOM OF THE OF PYRAMIDBOPSOUTH OF SAHARASynthesis Report